The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
Interesting Engineering on MSN1d
US FDA approves first-ever smart glasses with hearing aid for mild to moderate lossEssilorLuxottica's Nuance Audio Glasses receive FDA clearance for OTC sales in the US, revolutionizing hearing solutions with ...
Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ingredient as the company's ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Diabetes is the leading cause of kidney failure, which is one of the leading causes of death in the US and worldwide ... The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback